Deep domain expertise, a wealth of operational expertise and knowledge gained by helping our investee partners differentiate- this best defines us.

Bobba Venkatadri
Bobba Venkatadri
General Partner

A General Partner with Ventureast since 2007, Bobba brings over 36 years of corporate leadership experience in the pharmaceutical and life sciences fields in the US, EU and Asia. 

Prior to Ventureast, Bobba was Vice President of Pharmaceutical Manufacturing operations at Warner Lambert Co. USA. He managed five plants with a staff of about 2000. He served as President of Warner Lambert, Indonesia. He was Executive Vice president of Centocor Inc.(Division of J&J now) and was responsible for R&D, Clinical Development and operations. His group developed Reo-Pro, first successful monoclonal Antibody and Remicade, drug for Rheumatoid Arthritis (Sold about $7 in 2015). He was CEO of Molecular Biosystems which developed first ultra sound contrast agent, which is currently marketed by Mallinckrodt (about $250M in sales). 

Bobba also served as Senior V.P of Covance Biosciences (Now a division of Merck). He currently serves on the Boards of Sparsha, Diabetomics, Celes Care, Cancer Genetics India and an advisory Board member of Cumberland Pharma.

Investments managed by
Bobba Venkatadri
Learn More

India's largest home-healthcare company with 4,500 employees and 1 lakh patient visits/month

learn more
Latest News For
Bobba Venkatadri

No items found.